Emmaus Life Sciences (EMMA) Interest & Investment Income (2018 - 2026)
Emmaus Life Sciences (EMMA) posted Interest & Investment Income of $49,000 for Q2 2026, down 26.9% from $67,000 a year earlier and down 19.7% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Interest & Investment Income (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Emmaus Life Sciences was $240,000, up 76.5% year-over-year; for FY2025, it came in at $270,000, down 2.9% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of -19.5% (FY2020 to FY2025).
- In prior years, Emmaus Life Sciences' Interest & Investment Income was $278,000 in FY2024 (-59.2%), $681,000 in FY2023 (+0.1%), $680,000 in FY2022 (-10.6%) and $761,000 in FY2021 (-5.0%).
- The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q4 2024.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q3 2021, with growth of 225.4%; the weakest was Q3 2025, with a decline of 55.2%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $61,000 (Q1 2026), $65,000 (Q4 2025) and $65,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 49,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49,000.00 |
| Mar 31, 2026 | 61,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -149,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 135,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 167,000.00 |
| Sep 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 173,000.00 |
| Mar 31, 2023 | 160,000.00 |
| Dec 31, 2022 | 150,000.00 |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 133,000.00 |
| Mar 31, 2022 | 222,000.00 |
| Dec 31, 2021 | 188,000.00 |
| Sep 30, 2021 | 192,000.00 |
API Access
Emmaus Life Sciences Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();